Summit Trail Advisors LLC Acquires 236 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Summit Trail Advisors LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 8.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,179 shares of the company’s stock after buying an additional 236 shares during the period. Summit Trail Advisors LLC’s holdings in HCA Healthcare were worth $1,021,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the stock. Royal Bank of Canada boosted its stake in HCA Healthcare by 35.7% in the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock worth $1,219,121,000 after purchasing an additional 1,183,890 shares during the period. Capital World Investors grew its stake in HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after acquiring an additional 1,019,750 shares in the last quarter. Sanders Capital LLC lifted its stake in HCA Healthcare by 4.2% in the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after purchasing an additional 456,738 shares in the last quarter. Lee Danner & Bass Inc. bought a new position in shares of HCA Healthcare in the second quarter worth $131,527,000. Finally, TD Asset Management Inc boosted its stake in HCA Healthcare by 230.5% during the fourth quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock valued at $149,747,000 after buying an additional 385,854 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Price Performance

Shares of HCA stock opened at $404.66 on Friday. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $405.70. The stock has a market cap of $105.99 billion, a price-to-earnings ratio of 20.17, a PEG ratio of 1.46 and a beta of 1.67. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The business’s fifty day moving average is $370.57 and its 200 day moving average is $340.65.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter last year, the firm earned $4.29 earnings per share. Research analysts expect that HCA Healthcare, Inc. will post 22.46 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Truist Financial boosted their price objective on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday, June 28th. Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Finally, Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.